Cargando…

COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental()

INTRODUCTION: Due to the COVID-19 pandemic, in-person psychiatric care decreased, but mental disorders, such as post-traumatic stress disorder, anxiety, depression, obsessive compulsive symptoms and insomnia increased. Our objective was to describe the usefulness, advantages, disadvantages and limit...

Descripción completa

Detalles Bibliográficos
Autor principal: Urquizo Romo, Damaris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Asociación Colombiana de Psiquiatría. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458707/
https://www.ncbi.nlm.nih.gov/pubmed/36101855
http://dx.doi.org/10.1016/j.rcp.2022.08.005
_version_ 1784786348838748160
author Urquizo Romo, Damaris
author_facet Urquizo Romo, Damaris
author_sort Urquizo Romo, Damaris
collection PubMed
description INTRODUCTION: Due to the COVID-19 pandemic, in-person psychiatric care decreased, but mental disorders, such as post-traumatic stress disorder, anxiety, depression, obsessive compulsive symptoms and insomnia increased. Our objective was to describe the usefulness, advantages, disadvantages and limitations of telemedicine used in psychiatric patients’ clinical care before and during the COVID-19 pandemic. METHODS: A critical search was carried out on platforms such as PubMed, Cochrane, Lilacs and academic Google, in addition to an in-depth assessment of all the primary studies that answer our questions. RESULTS: Telepsychiatry is a tool that can help resolve the need for psychiatric care in a more comprehensive way. Advantages include cost reduction, enabling care provision to rural areas, the fact that its effectiveness is comparable to in-person care and its use is suitable in a variety of scenarios, and also that it helps reduce stigma and enables continuous training processes among medical staff. In the context of the current pandemic, it reduces the risk of transmission by maintaining biosecurity measures. However, there are also limitations in its use, such as the collection of medical insurance payments, mandatory in-person visits for examinations or procedures, difficulty in developing a doctor-patient relationship, and uncertainty about how to give informed consent and maintain the patient's privacy. Additionally, there is the difficulty in controlling the patient's environment, with the risk of the consultation taking place somewhere inappropriate, and the fact that there are certain populations which would not benefit from the use of telepsychiatry and areas where its use is made difficult by a greater digital gap. Based on these advantages and disadvantages, recommendations can be made when considering telepsychiatry as a medical care option.
format Online
Article
Text
id pubmed-9458707
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier España, S.L.U. on behalf of Asociación Colombiana de Psiquiatría.
record_format MEDLINE/PubMed
spelling pubmed-94587072022-09-09 COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental() Urquizo Romo, Damaris Rev Colomb Psiquiatr Artículo De Revisión INTRODUCTION: Due to the COVID-19 pandemic, in-person psychiatric care decreased, but mental disorders, such as post-traumatic stress disorder, anxiety, depression, obsessive compulsive symptoms and insomnia increased. Our objective was to describe the usefulness, advantages, disadvantages and limitations of telemedicine used in psychiatric patients’ clinical care before and during the COVID-19 pandemic. METHODS: A critical search was carried out on platforms such as PubMed, Cochrane, Lilacs and academic Google, in addition to an in-depth assessment of all the primary studies that answer our questions. RESULTS: Telepsychiatry is a tool that can help resolve the need for psychiatric care in a more comprehensive way. Advantages include cost reduction, enabling care provision to rural areas, the fact that its effectiveness is comparable to in-person care and its use is suitable in a variety of scenarios, and also that it helps reduce stigma and enables continuous training processes among medical staff. In the context of the current pandemic, it reduces the risk of transmission by maintaining biosecurity measures. However, there are also limitations in its use, such as the collection of medical insurance payments, mandatory in-person visits for examinations or procedures, difficulty in developing a doctor-patient relationship, and uncertainty about how to give informed consent and maintain the patient's privacy. Additionally, there is the difficulty in controlling the patient's environment, with the risk of the consultation taking place somewhere inappropriate, and the fact that there are certain populations which would not benefit from the use of telepsychiatry and areas where its use is made difficult by a greater digital gap. Based on these advantages and disadvantages, recommendations can be made when considering telepsychiatry as a medical care option. Published by Elsevier España, S.L.U. on behalf of Asociación Colombiana de Psiquiatría. 2022-09-09 /pmc/articles/PMC9458707/ /pubmed/36101855 http://dx.doi.org/10.1016/j.rcp.2022.08.005 Text en Crown Copyright © 2022 Published by Elsevier España, S.L.U. on behalf of Asociación Colombiana de Psiquiatría. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Artículo De Revisión
Urquizo Romo, Damaris
COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental()
title COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental()
title_full COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental()
title_fullStr COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental()
title_full_unstemmed COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental()
title_short COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental()
title_sort covid-19 y telepsiquiatría: un reto para el tratamiento de la salud mental()
topic Artículo De Revisión
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458707/
https://www.ncbi.nlm.nih.gov/pubmed/36101855
http://dx.doi.org/10.1016/j.rcp.2022.08.005
work_keys_str_mv AT urquizoromodamaris covid19ytelepsiquiatriaunretoparaeltratamientodelasaludmental